AFRM vs AMGN · P/E 590, rev $3.22B vs P/E 24, rev $36.75B
Affirm Holdings Inc (AFRM) versus Amgen Inc (AMGN) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Not investment advice. Open the AFRM and AMGN stock pages for the full models.
Not investment advice.